MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
823,001
Share change
+69,382
Total reported value
$48,001,022
Price per share
$58.37
Number of holders
51
Value change
+$4,645,659
Number of buys
24
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q1 2014

As of 31 Mar 2014, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 823,001 shares. The largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, ABSOLUTE INVESTMENT MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, COLUMBIA CAPITAL LLC, MONTAG A & ASSOCIATES INC, CREDIT SUISSE AG/, HighTower Advisors, LLC, and Virtu Financial LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.